Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 28;13(7):586.
doi: 10.3390/cells13070586.

Stem Cells Collection and Mobilization in Adult Autologous/Allogeneic Transplantation: Critical Points and Future Challenges

Affiliations
Review

Stem Cells Collection and Mobilization in Adult Autologous/Allogeneic Transplantation: Critical Points and Future Challenges

Michele Prisciandaro et al. Cells. .

Abstract

Achieving successful hematopoietic stem cell transplantation (HSCT) relies on two fundamental pillars: effective mobilization and efficient collection through apheresis to attain the optimal graft dose. These cornerstones pave the way for enhanced patient outcomes. The primary challenges encountered by the clinical unit and collection facility within a transplant program encompass augmenting mobilization efficiency to optimize the harvest of target cell populations, implementing robust monitoring and predictive strategies for mobilization, streamlining the apheresis procedure to minimize collection duration while ensuring adequate yield, prioritizing patient comfort by reducing the overall collection time, guaranteeing the quality and purity of stem cell products to optimize graft function and transplant success, and facilitating seamless coordination between diverse entities involved in the HSCT process. In this review, we aim to address key questions and provide insights into the critical aspects of mobilizing and collecting hematopoietic stem cells for transplantation purposes.

Keywords: CXCR4 antagonists; allogeneic; apheresis; autologous; mobilization; stem cell collection; transplant.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Specific gravity of blood cells and plasma. PLTs, Platelets; LYMs, Lymphocytes, MNCs, Mononuclear cells; CD34+, Hematopoietic stem cells; RBCs, Red blood cells.

Similar articles

Cited by

References

    1. Moog R. Management strategies for poor peripheral blood stem cell mobilization. Transfus. Apher. Sci. 2008;38:229–236. doi: 10.1016/j.transci.2008.04.002. - DOI - PubMed
    1. Snowden J.A., Sánchez-Ortega I., Corbacioglu S., Basak G.W., Chabannon C., de la Camara R., Dolstra H., Duarte R.F., Glass B., Greco R., et al. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: Current practice in Europe, 2022. Bone Marrow Transplant. 2022;57:1217–1239. doi: 10.1038/s41409-022-01691-w. - DOI - PMC - PubMed
    1. Carreras E., Dufour C., Mohty M., Kröger N. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies. Springer Nature; Cham, Switzerland: 2019. - PubMed
    1. Russell N.H., Hunter A., Rogers S., Hanley J., Anderson D. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet. 1993;341:1482. doi: 10.1016/0140-6736(93)90929-B. - DOI - PubMed
    1. Passweg J.R., Baldomero H., Chabannon C., Basak G.W., de la Cámara R., Corbacioglu S., Dolstra H., Duarte R., Glass B., Greco R., et al. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: Monitoring of activities and trends over 30 years. Bone Marrow Transplant. 2021;56:1651–1664. doi: 10.1038/s41409-021-01227-8. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources